Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function
- PMID: 2992919
- DOI: 10.1210/edrv-6-3-400
Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function
Abstract
A relatively large body of evidence now appears to support the existence of the essential ingredients for novel intraovarian IGF-driven control mechanisms. Indeed, evidence presented in this communication is in keeping with the possibility that the granulosa cell may be the site of IGF production, reception, and action. Although the relevance of IGFs to ovarian cell types other than the granulosa cell is largely unknown, one cannot at the present time exclude the possibility of nongranulosa cell contributions to intraovarian IGF production, reception, and action. Indeed, preliminary affinity cross-linking studies (Adashi, Resnick, Svoboda, Van Wyk and D'Ercole; unpublished data) suggest the existence of type-I and type-II receptors in nongranulosa cell compartments. The above notwithstanding, IGFs of granulosa (and possibly circulatory) origins may interact with granulosa cell autoreceptors either independently or in synergy with other granulosa cell agonists. According to this view, IGFs may act in the autocrine mode to stimulate granulosa cell replication on the one hand and promote granulosa cell differentiation on the other. Although proliferation and terminal differentiation may prove mutually exclusive under some circumstances, coexistence of the two processes is being increasingly recognized. In this context, some studies of porcine granulosa cells support a dual role for IGFs in granulosa cell ontogeny. As such, the IGFs can be added to a growing list of growth factors known to modulate granulosa cell growth and function, including EGF, PDGF, and FGF. Our findings indicate that Sm-C/IGF-I synergizes with FSH in the induction of rat granulosa cell aromatase activity at nanomolar concentrations compatible with its granulosa cell receptor binding affinity (thus far studied only in porcine cells. A role for Sm-C/IGF-I in the regulation of this key granulosa cell function would be in keeping with the possibility that Sm-C/IGF-I may partake in the assertion and maintenance of dominance by the selected follicle(s) or in promoting juvenile and early follicular development. Moreover, the ability of Sm-C/IGF-I to potentiate this and other FSH-driven ovarian functions may also account, at least in part, for the puberty-promoting effect of growth hormone. This permissive action of growth hormone has been initially suggested by observation in growth hormone-deficient rats, mice (dwarf mutants, and humans (sporadic, hereditary or acquired growth hormone deficiency.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
In vivo regulation of granulosa cell type I insulin-like growth factor receptors: evidence for an inhibitory role for the putative endogenous ligand(s) of the ovarian gonadotropin-releasing hormone receptor.Endocrinology. 1991 Jun;128(6):3130-7. doi: 10.1210/endo-128-6-3130. Endocrinology. 1991. PMID: 1645262
-
Somatomedin-C synergizes with follicle-stimulating hormone in the acquisition of progestin biosynthetic capacity by cultured rat granulosa cells.Endocrinology. 1985 Jun;116(6):2135-42. doi: 10.1210/endo-116-6-2135. Endocrinology. 1985. PMID: 3922741
-
Characterization and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor I in cultured rat granulosa cells.Endocrinology. 1988 Jan;122(1):194-201. doi: 10.1210/endo-122-1-194. Endocrinology. 1988. PMID: 2961555
-
Growth hormone and the insulin-like growth factor system in myogenesis.Endocr Rev. 1996 Oct;17(5):481-517. doi: 10.1210/edrv-17-5-481. Endocr Rev. 1996. PMID: 8897022 Review.
-
Insulin-like growth factor I as an intraovarian regulator: basic and clinical implications.Ann N Y Acad Sci. 1991;626:161-8. doi: 10.1111/j.1749-6632.1991.tb37910.x. Ann N Y Acad Sci. 1991. PMID: 1711822 Review.
Cited by
-
Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.Arch Gynecol Obstet. 1988;243(1):13-36. doi: 10.1007/BF00931548. Arch Gynecol Obstet. 1988. PMID: 3408273
-
Gonadotropin stimulation of ovarian fractalkine expression and fractalkine augmentation of progesterone biosynthesis by luteinizing granulosa cells.Endocrinology. 2008 Jun;149(6):2782-9. doi: 10.1210/en.2007-1662. Epub 2008 Feb 21. Endocrinology. 2008. PMID: 18292196 Free PMC article.
-
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4. Cochrane Database Syst Rev. 2020. PMID: 33347618 Free PMC article.
-
Effect of growth hormone administration on ameliorating pregnancy outcome in women with advanced maternal age and exploration of its optimized utilization.Front Endocrinol (Lausanne). 2023 Oct 25;14:1270897. doi: 10.3389/fendo.2023.1270897. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37964949 Free PMC article.
-
Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.J Endocrinol Invest. 1987 Dec;10(6):575-9. doi: 10.1007/BF03346997. J Endocrinol Invest. 1987. PMID: 3326891
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials